Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Preferred Dividend Payments (2025)

Lifecore Biomedical, Inc. \De\ has reported Preferred Dividend Payments over the past 1 years, most recently at -$2.3 million for Q2 2025.

  • For Q2 2025, Preferred Dividend Payments changed N/A year-over-year to -$2.3 million; the TTM value through May 2025 reached $192000.0, changed N/A, while the annual FY2025 figure was $192000.0, N/A changed from the prior year.
  • Preferred Dividend Payments for Q2 2025 was -$2.3 million at Lifecore Biomedical, Inc. \De\, down from $2.5 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $2.5 million in Q1 2025 and troughed at -$2.3 million in Q2 2025.